(Q52116119)

22 April 2018

title

A significant enhancement of therapeutic effect against hepatic metastases of M5076 in mice by a liposomal interleukin-2 (mixture). (English)

1 reference

22 April 2018

author name string

Eri Kanaoka

1

1 reference

22 April 2018

Kouji Takahashi

2

1 reference

22 April 2018

Takayoshi Yoshikawa

3

1 reference

22 April 2018

Hiroaki Jizomoto

4

1 reference

22 April 2018

Yoshitaka Nishihara

5

1 reference

22 April 2018

Naomi Uchida

6

1 reference

22 April 2018

Ryuji Maekawa

7

1 reference

22 April 2018

Koichiro Hirano

8

1 reference

22 April 2018

language of work or name

English

0 references

publication date

1 August 2002

1 reference

22 April 2018

Journal of Controlled Release

published in

1 reference

22 April 2018

volume

82

1 reference

22 April 2018

issue

2-3

1 reference

22 April 2018

page(s)

183-187

1 reference

22 April 2018

Active immunotherapy with transiently transfected cytokine-secreting tumor cells inhibits breast cancer metastases in tumor-bearing animals

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900083-4

7 January 2021

Pharmacokinetics of interleukin-2 in two anephric patients with metastatic renal cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900083-4

7 January 2021

Immunotherapy for colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900083-4

7 January 2021

Antitumor effect of interleukin-2 entrapped in liposomes on murine renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900083-4

7 January 2021

Cytokines in liposomes: preliminary studies with IL-1, IL-2, IL-6, GM-CSF and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900083-4

7 January 2021

Reevaluation of the superiority of polyethylene glycol-modified interleukin-2 over regular recombinant interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900083-4

7 January 2021

Hepatic immunopotentiation by galactose-entrapped liposomal IL-2 compound in the treatment of liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900083-4

7 January 2021

The development of IL-2 conjugated liposomes for therapeutic purposes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900083-4

7 January 2021

A novel and simple type of liposome carrier for recombinant interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900083-4

7 January 2021

Stabilization of aerosolized IFN-gamma by liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900083-4

7 January 2021

Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900083-4

7 January 2021

Inhibition of liver metastases of M 5076 tumor by liposome-entrapped adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900083-4

7 January 2021

Immunochemotherapy in B-16-melanoma-cell-transplanted mice with combinations of interleukin-2, cyclophosphamide, and PSK

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900083-4

7 January 2021

The involvement of parenchymal, Kupffer and endothelial liver cells in the hepatic uptake of intravenously injected liposomes effects of lanthanum and gadolinium salts

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900083-4

7 January 2021

10.1016/S0168-3659(02)00083-4

Identifiers

DOI

1 reference

22 April 2018

1 reference

22 April 2018